Planning NK Cell Therapy in Japan: A Guide to Treatment Cycles

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

NK cell therapy is a form of cancer immunotherapy that utilizes the body’s own immune cells to help fight disease. A common question from individuals considering this treatment is why it often involves a series of infusions rather than a single session. Understanding the concept of a treatment cycle is crucial for setting realistic expectations and for planning, especially for those traveling to Japan for medical care. This article explains the medical rationale behind multiple infusions and outlines how treatment schedules are typically structured.

Why a Treatment Cycle is Often Recommended

The primary goal of NK cell therapy is to bolster the body’s natural immune surveillance system by increasing the number and activity of Natural Killer (NK) cells. While a single infusion can significantly elevate the count of these specialized immune cells in the bloodstream, their lifespan within the body is finite. A treatment cycle, involving multiple infusions spaced over a period, is designed to maintain a consistently high level of active NK cells. This sustained immune pressure is thought to be more effective in targeting and managing abnormal cells over time. The strategy is not about a one-time attack, but about providing continuous support to the immune system.

Understanding the Rationale Behind Multiple Infusions

The effectiveness of the immune system against persistent threats like cancer cells relies on its ability to mount a sustained response. Here’s a breakdown of why repeated infusions are a cornerstone of many NK cell therapy protocols:

• Maintaining Cell Counts: After an infusion, the number of circulating NK cells gradually declines. Subsequent infusions are timed to replenish this population before it returns to its baseline level, thereby maintaining a heightened state of immune readiness.
• Overcoming Tumor Defenses: Cancer cells can develop mechanisms to evade the immune system. A sustained presence of highly active NK cells may help overcome these defenses more effectively than a short-lived spike from a single treatment.
• Supporting Overall Immune Function: NK cells don’t just attack abnormal cells directly; they also release signaling molecules (cytokines) that can help activate other parts of the immune system, such as T cells. A cyclical approach may help foster a more comprehensive and coordinated immune response.

Research in immunotherapy continues to explore the optimal frequency and duration of treatments to maximize the potential benefits while ensuring patient safety. The principle of repeated administration is a common theme in many immunotherapies, aimed at keeping the immune system engaged over the long term.

Planning Your NK Cell Therapy Schedule in Japan

For international patients considering treatment in Japan, understanding the typical structure of a treatment cycle is essential for logistical planning, such as arranging travel and accommodation in Osaka. While every treatment plan is personalized, a common approach involves an initial course of multiple infusions.

A treatment cycle often consists of a series of infusions, which might be administered every few weeks. The entire cycle could span several months. The exact number of infusions and the interval between them are not standardized; they are determined by a physician based on several factors:

• The patient’s overall health and medical condition.
• The specific goals of the therapy (e.g., used alongside standard cancer treatments, for recurrence prevention, or for general immune support).
• The patient’s response to the initial treatments.

The process begins with an initial consultation and blood draw. The collected cells are then sent to a specialized facility for culturing, which takes a few weeks. Once the expanded NK cells are ready, the infusion phase can begin. A physician will work with you to create a tentative schedule that aligns with your medical needs and travel plans.

Key Considerations Before Starting Treatment

NK cell therapy is a promising field, but it’s important to approach it with a clear understanding of what it entails. This treatment is not a substitute for standard cancer therapies such as surgery, chemotherapy, or radiation, but it can sometimes be used in conjunction with them under medical supervision.

In Japan, therapies like this are provided under the Act on the Safety of Regenerative Medicine, which establishes a framework for safety and quality control. At Grand Green Osaka Umekita Clinic, this therapy is offered as a private medical service, meaning it is not covered by Japanese public health insurance. All aspects of the treatment, including eligibility, the proposed treatment plan, potential risks and side effects (such as temporary fever or fatigue), and the total cost, must be thoroughly discussed with a doctor during a consultation. A physician’s assessment is required to determine if this therapy is a suitable option for your specific situation.

For a comprehensive overview of how NK cell therapy is administered at our clinic, including the flow from consultation to treatment, please review our detailed information page. You can find more details at the NK Cell Therapy page of the Grand Green Osaka Umekita Clinic.

Summary: A Personalized Approach to Immune Support

The use of treatment cycles in NK cell therapy is a strategic approach designed to provide sustained support to the body’s immune system. By administering multiple infusions over time, the therapy aims to maintain an elevated number of active NK cells to help in the ongoing surveillance and management of abnormal cells. The specific schedule—including the number of infusions and their frequency—is highly personalized and determined after a comprehensive medical evaluation.

If you are exploring cancer immunotherapy options in Japan, understanding the commitment involved in a treatment cycle is a vital first step. We encourage you to seek a professional medical consultation to discuss your individual circumstances. At Grand Green Osaka Umekita Clinic, located in the heart of Osaka, our team is available to provide detailed information and help you understand if this treatment aligns with your health goals.

1. 1Consultation & Blood DrawInitial assessment and cell collection
2. 2Cell CulturingExpanding NK cells in a specialized lab
3. 3NK Cell InfusionAdministering the cultured cells
4. 4Repeat InfusionsTo maintain a high level of NK cells

This diagram provides a simplified overview of the treatment process

References

• PMC: Current status and future perspective of natural killer cell therapy for cancer. (2023)
• PMC: Nanomaterial assisted natural killer cell therapy. (2025)
• PMC: Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future. (2021)
• PMC: First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia. (2019)
• MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.